Moderating Effects of Clinical and Social Factors on Fatigue Improvement After an Online Peer-Led Fatigue Self-management Intervention in People With Systemic Sclerosis: A Secondary Analysis of a Randomized Controlled Trial.
Yen T Chen, Nirali Shah, Afton L Hassett and 3 others
PMID 40383419WHAT IT FOUND
People with systemic sclerosis and moderate-to-severe fatigue who reported average or high informational support at baseline had greater fatigue improvement after a 12-week online peer-led self-management program compared to those with low support.
No other demographic, clinical, or psychological factor significantly moderated the treatment effect.
Key findings
01Baseline informational support significantly moderated the treatment effect, with participants having average to high support showing a greater reduction in fatigue scores compared to those with low support in the intervention group.
02The control group showed minimal difference in fatigue improvement between those with high versus low informational support.
03No other demographic, clinical, psychological, or social variables significantly moderated the treatment effect on fatigue improvement.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This was an exploratory secondary analysis, and the original study was not powered to detect moderation effects, meaning the results should be interpreted with caution. The sample was relatively homogeneous, consisting mostly of middle-aged, White, married, and highly educated females, which limits the generalizability of the demographic findings. The study only included participants with moderate-to-severe fatigue, so the findings do not apply to those with no or mild fatigue.
Declared interests
Dr. Khanna is a consultant to multiple pharmaceutical companies (including Acceleron, Abbvie, Actelion, Amgen, Bayer, BMS, Boehringer Ingelheim, CSL Behring, Corbus, Galapagos, Genentech/Roche, GSK, Horizon, Mitsubishi Tanabe Pharma, Sanofi-Aventis, and United Therapeutics) and has stock options in Eicos Sciences, Inc. The other authors declared no conflicts of interest.
The easy way to misread this
Do not assume that patients with low informational support will not benefit from the intervention. The study found that informational support moderated the *difference* in improvement between high and low support groups within the intervention arm, but it did not show that the low support group failed to improve compared to control.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →